Cargando…
Gastric Epithelial Cell Modality and Proton Pump Inhibitor
Proton pump inhibitors (PPIs) are now commonly used for the treatment of acid related diseases such as peptic ulcer and reflux esophagitis. Because of their ability to produce direct inhibition of the proton pump, PPIs provide more sustained increase of the gastric pH than H(2)-receptor (H(2)R) anta...
Autores principales: | Masaoka, Tatsuhiro, Suzuki, Hidekazu, Hibi, Toshifumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386521/ https://www.ncbi.nlm.nih.gov/pubmed/18545640 http://dx.doi.org/10.3164/jcbn.2008028 |
Ejemplares similares
-
Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008) -
Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors
por: Isomoto, Hajime, et al.
Publicado: (2009) -
Anti-Inflammatory and Anti-Oxidative Properties of Proton Pump Inhibitors
por: Naito, Yuji
Publicado: (2007) -
Introduction to serial reviews: Oxidative stress and digestive diseases
por: Suzuki, Hidekazu
Publicado: (2018) -
Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)